ArticleOne health outlook2026
One Health, many voices: advances and challenges in toxoplasmosis discussed at the VII Brazilian symposium and IV international symposium on toxoplasmosis.
Article in One health outlook, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The VII Brazilian Symposium on Toxoplasmosis (SIMBRATOX) and the IV International Symposium on Toxoplasmosis (SINTOX) were held remotely from October 6 to 8, 2025, under the theme "Toxoplasmosis - Strengthening the Connection between Science and Society for Global Health." The meeting brought together researchers, health professionals, policymakers, and representatives of civil society from Brazil and abroad, fostering interdisciplinary dialogue grounded in One Health and Global Health perspectives. Scientific sessions and roundtables addressed key dimensions of toxoplasmosis, including human, animal, and environmental transmission pathways; advances in therapeutics and vaccine research; veterinary and epidemiological surveillance; and health education strategies for prevention. Clinical discussions focused on congenital, ocular, and immunocompromised-associated toxoplasmosis, while other sessions examined food- and waterborne transmission, environmental contamination, and emerging challenges linked to parasite diversity. Social and legal panels highlighted patient advocacy, equity, and access to public policies as integral components of disease control. This commentary summarizes the main themes, debates, and perspectives that emerged during the three-day meeting, positioning toxoplasmosis as a model for operationalizing One Health approaches in complex infectious diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.